Written Question · S6W-38278 · Session 6
Whether any incentives exist in secondary care for urgent access to colonoscopy for patients with suspected inflammatory bowel disease (IBD…
The question
To ask the Scottish Government whether any incentives exist in secondary care for urgent access to colonoscopy for patients with suspected inflammatory bowel disease (IBD) who have not been referred on the cancer pathway, and what assessment it has made of introducing non-cancer specific local delivery plan (LDP) standards and incentives to improve access to colonoscopies for people with benign bowel conditions such as Crohn’s and colitis.
The answer
Patients continue to be seen based on their clinical urgency, and those referred with an urgent suspicion of cancer continue to be prioritised for scope-based diagnostic tests. The decision to appropriately prioritise patients based on their urgency is best placed with the clinicians responsible for their care.Health boards across NHS Scotland have local strategies in place to ensure patients with a clinical urgency, as well as those that have waited the longest, are investigated within an appropriate time by the most appropriate person. Referrals are clinically triaged at local board level and directed to the most appropriate waiting list.The Scottish Government expects Health Boards to ensure an investigation is undertaken, and the verified report is received by or made available to the requester, within a 6-week waiting times standard for key diagnostic tests and procedures. Health Boards must take all reasonable steps to ensure they comply with this standard.We know many people are still waiting too long and this is not good enough. We are determined do more and our Budget will provide a record £21.7 billion for health and social care.As part of planned care funding for 2025-26 we have provided over £10.5 million to territorial health boards across Scotland to support endoscopy activity and reduce waiting lists.To specifically support scope based diagnostics we have published an Endoscopy and Urology Diagnostic Recovery and Renewal Plan backed by £70 million. The plan focuses on key areas such as: Balancing Demand and Capacity; Workforce Training and Development; Infrastructure; and Innovation and Redesign.
In the Official Report
No contribution in the Official Report cites S6W-38278 by reference.